Yi Ming Pharmaceutical announced that the company previously planned to use no less than 35 million yuan and no more than 70 million yuan of its own capital to repurchase shares. The repurchase price should not exceed 25.74 yuan/share for equity incentives or employee stock ownership plans. As of September 11, 2026, the company's repurchase plan has been completed. A total of 3,944,200 shares have been repurchased, accounting for 2.0685% of the total share capital. The highest transaction price is 18 yuan/share, the lowest transaction price is 16.96 yuan/share, and the total repurchase amount is 69.8841 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.